Replying to @@Anydaynow
Yes, interesting thought.
On the one hand it's the science and excellent management that has brought us to $20.
On the other hand there is the inclination of human nature to say $1/share is more attractive and there must be more leverage/upside at that level than at $20. Which demeans the ultimate and only legitimate measuring stick, enterprise value/market cap.
So while we await Angelman results due very shortly, I'm thinking positively about that, with a consequent kick along (albeit gently) to the high twenties where we'll remain until news of either pre-clinical signals from that other handful of indications Jon speaks of, or emergence of takeover discussions ... or both.
Still think we're a $75 / $10B company with Angelman plus positives on the other indications. Yes, ultimately we're worth considerably more but the buyer will only pay his version of fair value pre-P3s on any of our products.
- Forums
- ASX - By Stock
- NEU
- NEU - Charts & Technical Analysis
NEU - Charts & Technical Analysis, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.64 |
Change
-0.150(1.09%) |
Mkt cap ! $1.762B |
Open | High | Low | Value | Volume |
$13.66 | $13.75 | $13.46 | $1.527M | 112.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 314 | $13.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.65 | 278 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 344 | 13.590 |
5 | 478 | 13.580 |
6 | 423 | 13.570 |
4 | 704 | 13.560 |
4 | 333 | 13.550 |
Price($) | Vol. | No. |
---|---|---|
13.620 | 37 | 2 |
13.630 | 741 | 5 |
13.640 | 565 | 6 |
13.650 | 539 | 6 |
13.660 | 584 | 5 |
Last trade - 10.29am 05/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |